EU AI Act's Machinery Exemption Creates Safety Blind Spot Until 2028—Ireland Must Prepare for the Gap
The May 2026 EU AI Omnibus deal exempts machinery regulation from direct AI Act oversight, deferring safety requirements until 2028. Here's what Irish manufacturers need to know.
The Machinery Exemption: What Just Changed
The May 7, 2026 EU AI Omnibus amendments introduced a regulatory carve-out that’s drawing quiet concern from safety engineers across Europe. Product-regulated high-risk AI systems embedded in machinery—think industrial robots, autonomous manufacturing equipment, and safety-critical automation—have been exempted from direct AI Act applicability. Instead, the European Commission will use delegated acts to layer AI-specific health and safety requirements onto existing machinery regulation by August 2, 2028.
This two-year deferral creates a compliance gray zone that Irish manufacturers and AI integrators need to understand now, not when enforcement suddenly tightens.
Why This Matters for Irish Industry
Ireland’s manufacturing sector—particularly in pharma, medtech, and advanced manufacturing—relies heavily on imported and domestically-integrated AI-powered machinery. Under the current exemption structure, a high-risk AI system controlling robotic assembly lines or quality inspection doesn’t face the same conformity assessment requirements as a standalone high-risk AI system until the Commission’s delegated acts take effect.
That sounds like relief. It’s actually a risk.
The Practical Problem
Manufacturers integrating AI into machinery face three competing regulatory frameworks right now:
- Existing Machinery Directive requirements (physical safety, CE marking)
- Current AI Act obligations (for some high-risk use cases)
- Forthcoming delegated acts (still undefined, arriving in 2027-2028)
The exemption means you could build a compliant system today under machinery rules, only to discover in 2028 that the AI-specific safety layer adds documentation, testing, or architectural requirements you didn’t anticipate. Retrofitting is costly. Planning ahead is essential.
What Irish Builders Should Do Now
1. Inventory your AI-in-machinery systems Map which of your products contain high-risk AI under Annex I (medical devices) or Annex III (employment, critical infrastructure). The exemption applies broadly—don’t assume you’re safe.
2. Monitor Commission communications The delegated acts won’t appear until late 2027 at earliest. Subscribe to artificialintelligenceact.eu and Ireland’s AI Office updates for early signals on how health and safety requirements will be integrated.
3. Design with future compliance in mind Adopt AI Act-aligned documentation practices now—model cards, risk assessments, performance monitoring logs. If the delegated acts align with AI Act principles (likely), you’ll have a head start.
4. Engage with your trade body Irish Manufacturing Research Association and similar bodies should be coordinating feedback to the Commission on practical implementation. Early input shapes better rules.
The Broader Question
This exemption raises a harder question: Is machinery regulation equipped to govern AI safety? The traditional machinery approach focuses on failure modes and hazard mitigation. AI safety adds algorithmic bias, adversarial robustness, and behavioral drift under distribution shift. The Commission’s delegated acts will determine whether it simply grafts AI Act requirements onto machinery rules or builds a genuinely integrated framework.
Ireland’s AI Office—due to be operational by August 2026—should be thinking now about how to advise manufacturers on this transition. The gap between exemption and full applicability is where compliance failures often hide.
Open Questions
- Will delegated acts prescribe specific AI risk assessment methodologies for machinery, or defer to industry standards?
- How will the Commission handle systems already deployed under the current exemption?
- Will there be transition periods for existing products, or hard switchover in August 2028?
The machinery exemption buys time. Spending it wisely—not just waiting—is what separates compliant manufacturers from scrambling ones.
Source: artificialintelligenceact.eu